Broncho-Vaxom is under clinical development by OM Pharma and currently in Phase I for Allergic Asthma. According to GlobalData, Phase I drugs for Allergic Asthma have a 78% phase transition success ...
Perhaps that’s why NHS Guys and St Thomas’ Trust writes “there is no firm evidence to support” drinking it once you’ve developed a UTI (though they do say it “may help” those with chronic UTIs or a ...